The antitumor lignan Nortrachelogenin sensitizes prostate cancer cells to TRAIL-induced cell death by inhibition of the Akt pathway and growth factor signaling
Authors: Emilia Peuhu, Preethy Paul, Mika Remes, Thomas Holmbom, Patrik Eklund, Rainer Sjöholm, John E. Eriksson
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.
